Establishment Labs Holdings (ESTA) Other financing activities (2017 - 2018)
Establishment Labs Holdings (ESTA) recorded quarterly Other financing activities of -$81000.0 in Q3 2018, down 112.98% quarter-over-quarter from $624000.0 in Q3 2017, and down 112.98% on a YoY basis from $624000.0 in Q3 2017.
Establishment Labs Holdings (ESTA) Other financing activities (2017 - 2018) Analysis & Trends
Establishment Labs Holdings' Other financing activities history runs 2 years deep, the most recent figure standing at -$81000.0 for Q3 2018.
- In Q3 2018, Other financing activities fell 112.98% year-over-year to -$81000.0; the TTM figure through Dec 2018 stood at $543000.0 (changed N/A YoY), while the FY2017 annual figure was $914000.0, changed N/A from the prior year.
- Other financing activities was -$81000.0 for Q3 2018 at Establishment Labs Holdings, down from $624000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $624000.0 in Q3 2017 to a low of -$81000.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -81,000.00 |
| Sep 30, 2018 | -81,000.00 |
| Sep 30, 2017 | 624,000.00 |
| Sep 30, 2017 | 624,000.00 |